Registry of Asthma Patients Initiating DUPIXENT®
Completed
Conditions studied: Asthma
In brief
The primary objective of the study is to characterize the patients who initiate treatment for asthma with DUPIXENT® in a real-world setting to understand the attributes of treated patients in real life. This includes characterization of: * Patient demographics (eg, gender, age, and race) * Patient baseline characteristics (eg, prior medications and procedures, medical history, asthma history, weight, height) The secondary objectives of the study are: * To characterize real-world use patterns of DUPIXENT® for asthma * To assess the long-term effectiveness of DUPIXENT® in asthma patients in a real-world setting * To assess effectiveness on comorbid type 2 inflammatory conditions in asthma patients treated with DUPIXENT® * To collect long-term safety data on study participants in the real-world setting
Key facts
- Study ID
- NCT04287621
- Run by
- Regeneron Pharmaceuticals
- People needed
- 718
- Starts
- 2020-03-02
- Expected to finish
- 2026-04-27
- Last updated by the study team
- 2026-06-04
Who can join
Age: 12 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Arizona Allergy & Immunology Research — Gilbert, Arizona, United States
- Medical Research of Arizona, a Division of Allergy, Asthma & Immunology Associates, Ltd. — Scottsdale, Arizona, United States
- Children's Hospital of Orange County — Orange, California, United States
- Riviera Allergy Medical Center — Redondo Beach, California, United States
- Allergy & Asthma Medical Group and Research, A PC — San Diego, California, United States
- Bensch Clinical Research, LLC — Stockton, California, United States
- Allianz Research Institute, Inc. — Westminster, California, United States
- Global Research Solutions — Hollywood, Florida, United States
- Memorial Healthcare System — Hollywood, Florida, United States
- Clinical Research Specialists, LLC — Kissimmee, Florida, United States
- Kratz Allergy & Asthma — Port Richey, Florida, United States
- GCP, Global Clinical Professionals — St. Petersburg, Florida, United States
- Allergy & Asthma Diagnostic Treatment Center — Tallahassee, Florida, United States
- Omni Allergy — Atlanta, Georgia, United States
- Columbus Regional Research Institute — Columbus, Georgia, United States
- IACT Health Southeast Lung Associates — Rincon, Georgia, United States
- Treasure Valley Medical Research — Boise, Idaho, United States
- Northwestern Medical Group Allergy & Immunology Clinic — Chicago, Illinois, United States
- The University of Chicago — Chicago, Illinois, United States
- NorthShore University Health System — Evanston, Illinois, United States
- Asthma and Allergy Center of Chicago — Oak Park, Illinois, United States
- Riley Hospital for Children at Indiana University Health — Indianapolis, Indiana, United States
- Velocity Clinical Research — Overland Park, Kansas, United States
- Dr. Henry J. Kanarek Allergy, Asthma & Immunology — Overland Park, Kansas, United States
- Clinical Research Center of Alabama, LLC — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.